The immune response to SARS-CoV-2 infection is generally determined by the antibodies developed against COVID-19 (specific immunoglobulin M (IgM), A (IgA) and G (IgG)) against different antigens (spike (and its subunits S1, S2), nucleocapsid, receptor-binding domain (RBD)). Here, CD79A is linked to COVID-19.